JP2022536663A5 - - Google Patents

Info

Publication number
JP2022536663A5
JP2022536663A5 JP2021573326A JP2021573326A JP2022536663A5 JP 2022536663 A5 JP2022536663 A5 JP 2022536663A5 JP 2021573326 A JP2021573326 A JP 2021573326A JP 2021573326 A JP2021573326 A JP 2021573326A JP 2022536663 A5 JP2022536663 A5 JP 2022536663A5
Authority
JP
Japan
Prior art keywords
haloalkyl
alkyl
compound
salt
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021573326A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536663A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037311 external-priority patent/WO2020252207A1/en
Publication of JP2022536663A publication Critical patent/JP2022536663A/ja
Publication of JP2022536663A5 publication Critical patent/JP2022536663A5/ja
Pending legal-status Critical Current

Links

JP2021573326A 2019-06-12 2020-06-11 統合的ストレス応答経路のモジュレーター Pending JP2022536663A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962860683P 2019-06-12 2019-06-12
US62/860,683 2019-06-12
PCT/US2020/037311 WO2020252207A1 (en) 2019-06-12 2020-06-11 Modulators of integrated stress response pathway

Publications (2)

Publication Number Publication Date
JP2022536663A JP2022536663A (ja) 2022-08-18
JP2022536663A5 true JP2022536663A5 (cg-RX-API-DMAC10.html) 2023-06-19

Family

ID=73745706

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573326A Pending JP2022536663A (ja) 2019-06-12 2020-06-11 統合的ストレス応答経路のモジュレーター

Country Status (6)

Country Link
US (1) US11318133B2 (cg-RX-API-DMAC10.html)
EP (1) EP3982965A4 (cg-RX-API-DMAC10.html)
JP (1) JP2022536663A (cg-RX-API-DMAC10.html)
CN (1) CN114466654A (cg-RX-API-DMAC10.html)
CA (1) CA3142748A1 (cg-RX-API-DMAC10.html)
WO (1) WO2020252207A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021508336A (ja) 2017-12-13 2021-03-04 プラクシス バイオテック エルエルシー 統合的ストレス応答経路の阻害剤
US11166942B2 (en) 2018-06-05 2021-11-09 Praxis Biotech LLC Inhibitors of integrated stress response pathway
JP2022536663A (ja) 2019-06-12 2022-08-18 プラクシス バイオテック エルエルシー 統合的ストレス応答経路のモジュレーター
KR20220151635A (ko) 2020-03-11 2022-11-15 에보텍 인터내셔널 게엠베하 통합 스트레스 반응 경로의 조절제
CA3195290A1 (en) 2020-10-22 2022-04-28 Holly Victoria Atton Modulators of the integrated stress response pathway
MX2023004677A (es) 2020-10-22 2023-05-24 Evotec Int Gmbh Moduladores de la via de respuesta integrada al estres.
ES2997335T3 (en) 2020-10-22 2025-02-17 Evotec Int Gmbh Modulators of the integrated stress response pathway
WO2022212902A1 (en) * 2021-04-02 2022-10-06 Altos Labs, Inc. Modulators of integrated stress response pathway

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8923209D0 (en) * 1989-10-14 1989-11-29 Wyeth John & Brother Ltd Heterocyclic compounds
GB2236751B (en) 1989-10-14 1993-04-28 Wyeth John & Brother Ltd Heterocyclic compounds
ID24525A (id) 1997-07-31 2000-07-20 Hoffmann La Roche Turunan-turunan hidroksikumaranon tersubstitusi-0 sebagai zat anti tumor dan zat antimetastatik
EP1403255A4 (en) 2001-06-12 2005-04-06 Sumitomo Pharma RHO KINASE INHIBITORS
US20050197350A1 (en) 2003-03-31 2005-09-08 Taisho Pharmaceutical Co., Ltd. Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
CA2881078C (en) * 2004-06-24 2018-10-02 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
JP4868731B2 (ja) 2004-11-17 2012-02-01 独立行政法人理化学研究所 哺乳動物培養細胞由来の無細胞タンパク質合成システム
WO2009151800A1 (en) 2008-05-07 2009-12-17 Merck & Co., Inc. Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
US8273900B2 (en) 2008-08-07 2012-09-25 Novartis Ag Organic compounds
US20100152160A1 (en) 2008-12-12 2010-06-17 Khamrai Uttam Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligands
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
CN102643268B (zh) * 2011-12-30 2014-05-21 沈阳药科大学 喹啉类及噌啉类化合物及其应用
WO2014072061A1 (en) 2012-11-09 2014-05-15 Biontech Ag Method for cellular rna expression
WO2014144952A2 (en) 2013-03-15 2014-09-18 Peter Walter Modulators of the eif2alpha pathway
CN106467541B (zh) * 2015-08-18 2019-04-05 暨南大学 取代喹诺酮类衍生物或其药学上可接受的盐或立体异构体及其药用组合物和应用
TW201808903A (zh) 2016-05-05 2018-03-16 嘉來克生命科學有限責任公司 整合應激途徑之調節劑
TW201808914A (zh) 2016-05-05 2018-03-16 嘉來克生命科學有限責任公司 整合應激途徑之調節劑
TWI920577B (zh) 2016-05-05 2026-04-01 美商嘉來克生命科學有限責任公司 整合應激途徑之調節劑
TW201808888A (zh) 2016-05-05 2018-03-16 嘉來克生命科學有限責任公司 整合應激途徑之調節劑
RU2018145734A (ru) * 2016-06-08 2020-07-14 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Химические соединения в качестве ингибиторов atf4 пути
CA3026983A1 (en) 2016-06-08 2017-12-14 Glaxosmithkline Intellectual Property Development Limited Chemical compounds
CN110730777A (zh) 2017-06-07 2020-01-24 葛兰素史密斯克莱知识产权发展有限公司 作为atf4通路抑制剂的化学化合物
WO2019008506A1 (en) 2017-07-03 2019-01-10 Glaxosmithkline Intellectual Property Development Limited N- (3- (2- (4-CHLOROPHENOXY) ACETAMIDO) BICYCLO [1.1.1] PENTAN-1-YL) -2-CYCLOBUTANE-1-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER DISEASES
EP3649108A1 (en) 2017-07-03 2020-05-13 GlaxoSmithKline Intellectual Property Development Limited 2-(4-chlorophenoxy)-n-((1 -(2-(4-chlorophenoxy)ethynazetidin-3-yl)methyl)acetamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseases
IL301709B2 (en) 2017-08-09 2025-07-01 Denali Therapeutics Inc Compounds, compositions and methods
TW201920129A (zh) 2017-09-01 2019-06-01 美商戴納立製藥公司 化合物、組合物及方法
UY37958A (es) 2017-11-02 2019-05-31 Abbvie Inc Moduladores de la vía de estrés integrada
MX2020004537A (es) 2017-11-02 2020-10-05 Calico Life Sciences Llc Moduladores de la vía integrada del estrés.
EP3704125B1 (en) 2017-11-02 2026-03-11 Calico Life Sciences LLC Modulators of the integrated stress pathway
UY37956A (es) 2017-11-02 2019-05-31 Abbvie Inc Moduladores de la vía de estrés integrada
JP2021501785A (ja) 2017-11-02 2021-01-21 カリコ ライフ サイエンシーズ エルエルシー 統合的ストレス経路の調節剤
SG11202004009TA (en) 2017-11-02 2020-05-28 Calico Life Sciences Llc Modulators of the integrated stress pathway
BR112020008825A2 (pt) 2017-11-02 2020-10-20 Calico Life Sciences Llc moduladores da via de estresse integrada
UY37957A (es) 2017-11-02 2019-05-31 Abbvie Inc Moduladores de la vía de estrés integrada
MX2020004538A (es) 2017-11-02 2020-09-18 Calico Life Sciences Llc Moduladores de la vía de estrés integrada.
JP2021508336A (ja) 2017-12-13 2021-03-04 プラクシス バイオテック エルエルシー 統合的ストレス応答経路の阻害剤
WO2019183589A1 (en) 2018-03-23 2019-09-26 Denali Therapeutics Inc. Modulators of eukaryotic initiation factor 2
WO2019193540A1 (en) 2018-04-06 2019-10-10 Glaxosmithkline Intellectual Property Development Limited Heteroaryl derivatives of formula (i) as atf4 inhibitors
WO2019193541A1 (en) 2018-04-06 2019-10-10 Glaxosmithkline Intellectual Property Development Limited Bicyclic aromatic ring derivatives of formula (i) as atf4 inhibitors
US11166942B2 (en) 2018-06-05 2021-11-09 Praxis Biotech LLC Inhibitors of integrated stress response pathway
JP2021529814A (ja) 2018-07-09 2021-11-04 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited 化学化合物
WO2020031107A1 (en) 2018-08-08 2020-02-13 Glaxosmithkline Intellectual Property Development Limited Chemical compounds
TW202545902A (zh) 2018-10-11 2025-12-01 美商嘉來克生命科學有限責任公司 整合應激路徑之前藥調節劑
EP3924341A4 (en) 2019-02-13 2022-11-02 Denali Therapeutics Inc. Compounds, compositions and methods
CR20210426A (es) 2019-02-13 2021-09-30 Denali Therapeutics Inc Compuestos, composiciones y métodos
SG11202107871UA (en) 2019-02-25 2021-08-30 Praxis Biotech LLC Inhibitors of integrated stress response pathway
US20220177456A1 (en) 2019-03-06 2022-06-09 Denali Therapeutics Inc. Compounds, compositions and methods
MX2021012904A (es) 2019-04-23 2022-01-18 Evotec Int Gmbh Moduladores de la via de respuesta al estres integrada.
WO2020216766A1 (en) 2019-04-23 2020-10-29 Evotec International Gmbh Modulators of the integrated stress response pathway
AR118836A1 (es) 2019-04-30 2021-11-03 Calico Life Sciences Llc Moduladores de la vía de tensión integrada
PH12021552759A1 (en) 2019-04-30 2022-07-04 Abbvie Inc Substituted cycloalkyls as modulators of the integrated stress pathway
JP2022536901A (ja) 2019-06-12 2022-08-22 プラクシス バイオテック エルエルシー 統合的ストレス応答経路の阻害剤
JP2022536663A (ja) 2019-06-12 2022-08-18 プラクシス バイオテック エルエルシー 統合的ストレス応答経路のモジュレーター

Similar Documents

Publication Publication Date Title
JP2022536901A5 (cg-RX-API-DMAC10.html)
RU2020122711A (ru) Ингибиторы пути интегрированной реакции на стресс
JP2022521605A5 (cg-RX-API-DMAC10.html)
JP2021527044A5 (cg-RX-API-DMAC10.html)
JP2022536663A (ja) 統合的ストレス応答経路のモジュレーター
US11739069B2 (en) Modulators of resistant androgen receptor
CA3008312A1 (en) Novel fluorinated quinazoline derivatives as egfr inhibitors
JP2018527334A (ja) 治療化合物としてのn−(ピリジン−2−イル)−4−(チアゾール−5−イル)ピリミジン−2−アミン誘導体
CN108137672B (zh) 用于生产具有igg fc结构域的融合蛋白的方法
WO2020252205A1 (en) Inhibitors of integrated stress response pathway
JP2021527044A (ja) 統合的ストレス応答経路の阻害剤
US9808447B2 (en) Inhibitors of Rho associated protein kinases (ROCK) and methods of use
WO2020033782A1 (en) Activators of the retinoic acid inducible gene "rig-1" pathway and methods of use thereof
Chen et al. Discovery of Orally Available Retinoic Acid Receptor-Related Orphan Receptor γ‑t/Dihydroorotate Dehydrogenase Dual Inhibitors for the Treatment of Refractory Inflammatory Bowel Disease
TW200424184A (en) Cyclization process for substituted benzothiazole derivatives
RU2022100043A (ru) Ингибиторы пути интегрированной реакции на стресс
RU2020143544A (ru) Ингибиторы пути комплексной стресс-реакции
US11472815B2 (en) 1,4-diphenyl-1H-imidazole and 2,4-diphenylthiazole derivatives and preparation method therefor and use thereof
WO2020036574A1 (en) Activators of the retinoic acid inducible gene "rig-i' pathway and methods of use thereof
JP5894351B2 (ja) 細胞毒性活性を有する2,3’−アンヒドロ−2’−デオキシ−5−フルオロウリジン誘導体、その製造プロセスおよび使用
RU2021128007A (ru) Ингибиторы пути интегрированной реакции на стресс
US20230042881A1 (en) Modulators of integrated stress response pathway
HK40074323A (en) Modulators of integrated stress response pathway
CN104177289B (zh) 氯己氧基乙氧基乙基化合物及其药物组合物和用途
Soni et al. Synthesis, Biological Evaluation, Molecular Docking and Md Simulation of (Z)-N'-(3-Phenoxybenzylidene)-2-(Substituted-Amino Aryl) Acetohydrazide